Hostname: page-component-5f56664f6-n72nm Total loading time: 0 Render date: 2025-05-07T11:41:33.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Measuring Health Outcomes for Older People Using the Sage Database

Published online by Cambridge University Press:  29 November 2010

Giovanni Gambassi ,
Kate L. Lapane ,
Antonio Sgadari ,
Francesco Landi ,
Vincent Mor  and
Roberto Bernabei
Giovanni Gambassi
Affiliation:
Università Cattolica del Sacro Cuore
Kate L. Lapane
Affiliation:
Brown University
Antonio Sgadari
Affiliation:
Università Cattolica del Sacro Cuore
Francesco Landi
Affiliation:
Università Cattolica del Sacro Cuore
Vincent Mor
Affiliation:
Brown University
Roberto Bernabei
Affiliation:
Università Cattolica del Sacro Cuore
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We establish the potential for outcomes evaluation of a long-term care population-based dataset. Data come from the Health Care Financing Administration's case-mix and quality demonstration project including all Medicare/ Medicaid certified homes of five U.S. states during 1992–1994. Using the Minimum Data Set, we identified nearly 70,000 residents over 65 years of age with congestive heart failure. We provide a preliminary analysis of pharmacotherapy of congestive heart failure and its effects on decline in physical functioning. Functional outcome, expressed as the rate of ADL decline, was improved for patients on combination therapy relative to those on digoxin or ACE-inhibitors alone. The availability of a population-based data set provides a means of evaluating current policies and practices.

Résumé

RÉSUMÉ

Cet article cherche à établir le potentiel d'évaluation des programmes d'une base de données sur les soins de longue durée dans la communauté. Les données proviennent d'un projet-pilote sur la qualité et la clientèle du Health Care Financing Administration, incluant tous les établissements couverts par Medicare/ Medicaid de cinq états américains entre 1992 et 1994. À l'aide du Minimum Data Set, 70 000 résidents de plus de 65 ans souffrant d'insuffisance cardiaque globale ont été identifiés. L'analyse préliminaire de la pharmacothérapie de l'insuffisance cardiaque globale et de ses effets sur le déclin des fonctions physiques est présentée. L'état des fonctions physiques, mesuré par le taux de déclin des activités instrumentales de la vie quotidienne des patients qui suivent une thérapie combinée s'améliore par rapport à ceux qui prennent seulement de la digoxine ou des inhibiteurs de l'enzyme convertissant l'angiotensine. La disponibilité d'un ensemble de donnees sur la population fournit done une méthode d'évaluation des politiques et des pratiques courantes.

Keywords

AgedAdministrative DatabaseHealth OutcomesMinimum Data SetNursing HomeObservational StudiesPharmaco-epidemiologyAîné(e)sbase de données administrativerésultats de santéminimum data setmaison de soins infirmiersétudes par observationpharmaco-épidémiologie
Type
Research Article
Information
Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 19 , supplement S2 , Fall/Automne 2000 , pp. 67 - 86
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Canadian Association on Gerontology 2000

Footnotes

1

Center for Gerontology and Health Care Research, Brown University, Box G-B222, 171 Meeting Street, Providence, RI, 02912, (Kate_Lapane@brown.edu)

References

1. Greengross, S, Murphy, E, Quam, L, Rochon, P. Aging: a subject that must be at the top of world agendas. BMJ 1997;315:1028–9.CrossRefGoogle Scholar
2. Avorn, J. Medication use and the elderly: current status and opportunities. Health Affairs Spring 1995;276–86.CrossRefGoogle ScholarPubMed
3. Sackett, DL, Rosenberg, WMC, Gray, JAM, Haynes, RB, Richardson, WS. Evidence based medicine: what it is and what it isn't. It's about integrating individual clinical expertise and the best external evidence. BMJ 1996;312:71–2.CrossRefGoogle Scholar
4. Sibbald, B, Roland, M. Why are randomised controlled trials important? BMJ 1998;316:201.CrossRefGoogle ScholarPubMed
5.Evidence-Based Medicine Working Group. Evidence-Based Medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420–5.CrossRefGoogle Scholar
6. Levin, A. Evidence-based medicine gaining supporters. Ann Intern Med 1998;128:334–6.CrossRefGoogle ScholarPubMed
7. Charlton, BG. Randomized clinical trials: the worst kind of epidemiology? Nature Medicine 1995;1:1101–2.CrossRefGoogle ScholarPubMed
8. Taubes, G. Looking for the evidence in medicine. Science 1996;272:22–4.CrossRefGoogle ScholarPubMed
9. Feinstein, AR, Horwitz, RI. Problems in the evidence of evidence-based medicine. Am J Med 1997;103:529–35.CrossRefGoogle ScholarPubMed
10. Maynard, A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet 1997;349:126–8.CrossRefGoogle ScholarPubMed
11. Kerridge, I, Lowe, M, Henry, D. Ethics and evidence based medicine. BMJ 1998;316:1151–3.CrossRefGoogle ScholarPubMed
12. Naylor, CD. Grey zone of clinical practice: some limits to evidence-based medicine. Lancet 1995;345:840–2.CrossRefGoogle Scholar
13. Knottnerus, JA, Dinant, GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997;315:1109–10.Google ScholarPubMed
14. Schneider, LS, Olin, JT, Lyness, SZ, Chui, HC. Eligibility of Alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc 1997;45:923–8.CrossRefGoogle ScholarPubMed
15. Green, J, Britten, N. Qualitative research and evidence based medicine. BMJ 1998;316:1230–2.CrossRefGoogle ScholarPubMed
16. Gurwitz, JH, Col, NF, Avorn, J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417–22.CrossRefGoogle ScholarPubMed
17. Avorn, J. Including elderly people in clinical trials, BMJ 1997;315:1033–4.CrossRefGoogle ScholarPubMed
18. Bugeja, G, Kumar, A, Banerjee, AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997;315:1059.CrossRefGoogle ScholarPubMed
19. Lye, M. Access to advances in cardiology. Lancet 1997;350:1162–3.CrossRefGoogle ScholarPubMed
20. Evans, JG. Evidence-based and evidence-biased medicine. Age-Ageing 1995;24:461–3.CrossRefGoogle ScholarPubMed
21. Black, N. Developing high quality clinical databases: the key to a new research paradigm. BMJ 1997;315:381–2.CrossRefGoogle Scholar
22. Hornberger, J, Wrone, E. When to base clinical policies on observational versus randomized trial data. Ann intern Med 1997;127:697–703.CrossRefGoogle ScholarPubMed
23. Horwitz, RI, Viscoli, CM, Clemens, JD, Sadock, RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990;89:630–8.CrossRefGoogle ScholarPubMed
24. Black, N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215–8.CrossRefGoogle ScholarPubMed
25. Walker, AM. Common language. Pharmacoepidemiol Drug Safety 1996;5:415–8.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
26. Engels, EA, Spitz, MR. PACE-setting research. Lancet 1997;350:677–8.CrossRefGoogle ScholarPubMed
27. Beers, MH, Ouslander, JG, Fingold, SG, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684–9.CrossRefGoogle ScholarPubMed
28. Willcox, SM, Himmelstein, DU, Woolhandler, S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292–6.CrossRefGoogle ScholarPubMed
29. Rubenstein, LZ. An overview of comprehensive geriatric assessment: rationale, history, program models, basic components. In: Rubenstein, LZ, Wieland, D, Bernabei, R, eds. Geriatric assessment technology: the state of the art. Milano, Italia: Kurtis; 1995:11–26.Google Scholar
30. Avorn, J, Gurwitz, JH. Drug use in the nursing home. Ann Intern Med 1995;123:195–204.CrossRefGoogle ScholarPubMed
31. Beers, MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531–6.CrossRefGoogle ScholarPubMed
32. Bernabei, R, Gambassi, G, Mor, V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250–2.CrossRefGoogle ScholarPubMed
33. Bernabei, R, Gambassi, G, Lapane, K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Med Sci 1999;54:M25–33.CrossRefGoogle ScholarPubMed
34. Morris, JN, Hawes, C, Fries, BE et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990;30:293–7.CrossRefGoogle ScholarPubMed
35. Gambassi, G, Landi, F, Peng, L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36:167–79.CrossRefGoogle ScholarPubMed
36. Bernabei, R, Gambassi, G, Lapane, K, et al. Management of pain in elderly cancer patients. JAMA 1998;279:1877–82.CrossRefGoogle Scholar
37. Gambassi, G, Lapane, K, Sgadari, A, et al. Prevalence, clinical correlates and treatment of hypertension in institutionalized elderly. Arch Intern Med 1998;158:2377–85.CrossRefGoogle Scholar
38. Landi, F, Gambassi, G, Lapane, K, et al. Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 1998;9:347–56.CrossRefGoogle ScholarPubMed
39.Minimum Data Set Plus Training Manual. Natick, MA: Eliot Press; 1991.Google Scholar
40. Hawes, C, Morris, JN, Phillips, CD, Mor, V, Fries, BE, Nonemaker, S. Reliability estimates for the Minimum Data Set for Nursing Home Resident Assessment and care screening (MDS) Gerontologist 1995; 2:172–8.CrossRefGoogle Scholar
41. Morris, JN, Nonemaker, S, Murphy, K, et al. A commitment to change: revision of the HCFA's RAI. J Am Geriatr Soc 1997;45:1011–6.CrossRefGoogle ScholarPubMed
42. Sgadari, A, Morris, JN, Fries, BE, et al. Effort to establish the reliability of the RAI. Age Ageing 1997;26:27–30.CrossRefGoogle Scholar
43. Hawes, C, Phillips, CD, Mor, V, et al. The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality. J Am Geriatr Soc 1997;45:977–85.CrossRefGoogle ScholarPubMed
44. Fries, BE, Hawes, C, Morris, JN, Phillips, CD, Mor, V, Park, PS. Effect of the national Resident Assessment Instrument on selected health conditions and problems. J Am Geriatr Soc 1997;45:994–1001.CrossRefGoogle ScholarPubMed
45. Mor, V, Intrator, O, Fries, BE, et al. Changes in hospitalization associated with introducing the resident assessment instrument. J Am Geriatr Soc 1997;45:1002–10.CrossRefGoogle ScholarPubMed
46. Phillips, C, Morris, JN, Hawes, C, et al. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status. J Am Geriatr Soc 1997;45:986–93.CrossRefGoogle ScholarPubMed
47. Morris, JN, Fries, BE, Mehr, DR et al. MDS Cognitive Performance Scale. J Gerontol 1994;49:M174–82.CrossRefGoogle ScholarPubMed
48. Mor, V, Branco, K, Fleishman, J, et al. The structure of social engagement among nursing home residents. J Gerontol 1995;50B:P1–8.CrossRefGoogle Scholar
49. Voelkl, JE, Fries, BE, Galecki, AT. Predictors of nursing home resident's participation in activity programs. Gerontologist 1995;35:44–51.CrossRefGoogle Scholar
50. Blaum, CS, O'Neill, EF, Clements, KM, Fries, BE, Fiatarone, MA. Validity of the Minimum Data Set for assessing nutritional status in nursing home residents. Am J Clin Nutr 1997;66:787–94.CrossRefGoogle ScholarPubMed
51. Williams, BC, Li, Y, Fries, BE, Warren, RL. Predicting patient scores between the Functional Independence measure and the Minimum Data Set: development and performance of a FIM-MDS “crosswalk”. Arch Phys Med Rehabil 1997;78:48–54.CrossRefGoogle ScholarPubMed
52. Resnick, HE, Fries, BE, Verbrugge, LM. Windows to their world: the effect of sensory impariments on social engagement and activity time in nursing home residents. J Gerontol Soc Sci 1997;52:S135–44.CrossRefGoogle Scholar
53. Resnick, NM, Brandeis, GH, Baumann, MM, Morris, JN. Evaluating a national assessment strategy for urinary incontinence in nursing home residents: reliability of the Minimum Data Set and validity of the Resident Assessment Protocol. Neurourol Urodyn 1996;15:583–98.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
54. Fried, TR, Mor, V. Frailty and hospitalization of long-term stay nursing home residents. J Am Geriatr Soc 1997;45:265–9.CrossRefGoogle ScholarPubMed
55. Hartmaier, SL, Sloane, PD, Guess, HA, Koch, GG. The MDS cognition scale: a valid instrument for identifying and staging nursing home residents with dementia using the Minimum Data Set. J Am Geriatr Soc 1994;42:1173–9.CrossRefGoogle ScholarPubMed
56. Hartmaier, SL, Sloane, PD, Guess, HA, Koch, GG, Mitchell, CM, Phillips, CD. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol Med Sci 1995;50:M128–33.CrossRefGoogle ScholarPubMed
57. Frederiksen, K, Tariot, P, De, Jonghe E. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc 1996;44:305–9.CrossRefGoogle ScholarPubMed
58. Fries, BE, Schneider, DP, Foley, WJ, Gavazzi, M, Burke, R, Cornelius, E. Refining a case-mix measure for nursing homes: resource utilization groups (RUG-III). Med Care 1994;32:668–85.CrossRefGoogle Scholar
59. Fries, BE, Mehr, DR, Schneider, D, Foley, WJ, Burke, R. Mental dysfunction and resource use in nursing homes. Med Care 1993;31:898–920.CrossRefGoogle ScholarPubMed
60. Master Drug Data Base (MDDB) Documentation manual. Indianapolis, IN: MediSpan Inc.; 1995.Google Scholar
61.Massachussets Extended Care Federation Survey, Certification and Enforcement. The Long-Term Care Survey Regulations, Forms, Intepretative Guidelines. Dedham, MA, 1995.Google Scholar
62. Zinn, JS, Mor, V. Nursing home special care units: distribution by type, state and facility characteristics. Gerontologist 1994;34:371–7.CrossRefGoogle ScholarPubMed
63. Banaszak-Holl, J, Zinn, JS, Mor, V The impact of market and organizational characteristics on nursing care facility service innovation: a resource dependency perspective. Health Serv Res 1996;31:97–117.Google ScholarPubMed
64. Stambler, H. The Area Resource File: a brief look. Public Health Reports 1988;103:184–8.Google ScholarPubMed
65. Stafford, RS, Saglam, D, Blumenthal, D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460–4.CrossRefGoogle ScholarPubMed
66. McDermott, MM, Feinglass, J, Lee, P, et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. Am Heart J 1997;134:901–9.CrossRefGoogle ScholarPubMed
67. Rich, MW, Brooks, K, Luther, P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990–1995. Am Heart J 1998:135:367–72.CrossRefGoogle ScholarPubMed
68. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429–35.CrossRefGoogle Scholar
69. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.CrossRefGoogle Scholar
70. Garg, R, Yusuf, S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995:273:1450–6.CrossRefGoogle ScholarPubMed
71. Newman, J, Ahmed, O, Hyngstrom, T, et al. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103–8.Google Scholar
72. Deedwania, PC. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve. Arch Intern Med 1997;157:2409–12.CrossRefGoogle Scholar
73. Wennberg, JE, Freeman, JL, Shelton, RM, et al. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med 1989:321:1168–73.CrossRefGoogle ScholarPubMed
74. Wennberg, JE. The geography of health care in the United States. In: Wennberg, JE, McAndrew, Cooper M, eds. The Dartmouth atlas of health care. Chicago, IL: American Hospital Publishing, Inc.; 1996:11–35.Google Scholar
75. Philbin, EF, Andreaou, C, Rocco, TA, Lynch, LJ, Baker, SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832–8.CrossRefGoogle ScholarPubMed
76. Raleigh, VS. The demographic timebomb. BMJ 1997;315:442–3.CrossRefGoogle ScholarPubMed
77. Redelmeier, DA, Tan, SH, Booth, GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516–20.CrossRefGoogle ScholarPubMed
78. Kane, RL. Improving the quality of long-term care. JAMA 1995;273:1376–80.CrossRefGoogle ScholarPubMed
79.Institute of Medicine. Health outcomes for older people. JC, Feasley, ed. Washington DC: National Academic Press, 1996.Google Scholar
80. Epstein, RS, Sherwood, LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832–7.CrossRefGoogle ScholarPubMed
81. Hunter, DJ, Fairfield. Disease management. BMJ 1997;314:50–3.CrossRefGoogle Scholar
82. Phillips, CD, Sloane, PD, Hawes, C, et al. Effects of residence in Alzheimer disease special care units on functional outcomes. JAMA 1997;278:1340–4.CrossRefGoogle ScholarPubMed
83. Zimmerman, DR, Karon, SL, Arling, G, et al. Developing and testing of nursing home quality indicators. Health Care Financing Review 1995;16(4):107–27.Google Scholar
84. Berlowitz, DR, Brandeis, GH, Moskowitz, MA. Using administrative databases to evaluate long-term care. J Am Geriatr Soc 1997;45:618–23.CrossRefGoogle ScholarPubMed
85. Bradley, EH, Besdine, R. Outcomes-based quality improvement: reducing the data collection burden. J Am Geriatr Soc 1998;46:534–5.CrossRefGoogle ScholarPubMed
86. Teresi, JA, Holmes, D. Should MDS data be used for research? Gerontologist 1992;32:148–9.CrossRefGoogle ScholarPubMed
87. Ouslander, JG. Maximizing the Minimum Data Set. J Am Geriatr Soc 1994;42:1212–3.CrossRefGoogle ScholarPubMed
88. Black, D, Bowman, C. Community institutional care for frail elderly people. BMJ 1997;315:441–2.CrossRefGoogle ScholarPubMed
89. Schroll, M. Effects of systematic geriatric assessment. Lancet 1997;350:604–5.CrossRefGoogle ScholarPubMed
90. Steel, K. Research on aging: an agenda for all nations individually and collectively. JAMA 1997;278:1374–5.CrossRefGoogle ScholarPubMed
91. Fries, BE, Schroll, M, Hawes, C, Gilgen, R, Jonsson, PV, Park, P. Approaching cross-national comparisons of nursing home residents. Age Ageing 1997;26(suppl. 2):13–8.CrossRefGoogle ScholarPubMed
92. Phillips, CD, Hawes, C, Mor, V, Fries, BE, Morris, JN, Nennstiel, ME. Facility and area variation affecting the use of physical restraints in nursing homes. Med Care 1996;34:1149–62.CrossRefGoogle ScholarPubMed
93. Gatsonis, CA, Epstein, AM, Newhouse, JP, Normand, SL, McNeil, BJ. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction. Med Care 1995;33:625–42.CrossRefGoogle ScholarPubMed